Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urinary markers for prostate cancer.

Michelle R Downes1, Jennifer C Byrne, Stephen R Pennington

  • 1Proteome Research Centre, UCD Conway Institute of Biomolecular and Biomedical Research, Mater Misericordiae University Hospital, University College Dublin, Ireland. michelle.downes@ucd.ie

BJU International
|November 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improved prostate cancer grading by incorporating Gleason pattern quantification, invasive cribriform and intraductal carcinoma in the new QUICC-score.

Annals of diagnostic pathology·2026
Same author

The Value of Systematic Versus Targeted Sampling in Prostate Cancer Detection and the Identification of Adverse Pathologic Features: A Retrospective Review of Over 1400 Combined Prostate Biopsies.

The American journal of surgical pathology·2026
Same author

Eosinophilic Pattern of Chromophobe Renal Cell Carcinoma is More Aggressive Than the Classic Pattern: A Comprehensive Morphologic and Genomic Analysis.

The American journal of surgical pathology·2026
Same author

Response to Comment on "Reflex somatic testing for the detection of FGFR alterations in urinary tract carcinomas: a dual-institutional experience".

American journal of clinical pathology·2026
Same author

Redefining the Landscape of Genitourinary Cancer Precursors: The International Society of Urological Pathology Consensus Recommendations.

European urology·2026
Same author

Response to Methodological and reporting considerations for reflex FGFR testing in urinary tract carcinomas.

American journal of clinical pathology·2026
Same journal

Cancer detection in the European Randomised Study of Screening for Prostate Cancer (ERSPC).

BJU international·2026
Same journal

Outcomes of maintenance BCG versus gemcitabine/docetaxel following BCG induction in NMIBC.

BJU international·2026
Same journal

A call for regimen agnostic circulating tumour DNA-guided adjuvant selection in muscle-invasive bladder cancer.

BJU international·2026
Same journal

Ablative radiotherapy in castration-resistant prostate cancer.

BJU international·2026
Same journal

Longitudinal circulating tumour DNA identifies patients at high risk of upstaging and recurrence in non-muscle-invasive bladder cancer.

BJU international·2026
Same journal

Venous thromboembolism after penile cancer surgery: a UK PeCaN study.

BJU international·2026
See all related articles

Novel urine tests show promise for diagnosing prostate cancer, offering a less invasive screening alternative. Further research is needed to validate these urinary biomarkers for reliable detection of the malignancy.

Area of Science:

  • Urology
  • Oncology
  • Biomarker Discovery

Background:

  • Prostate cancer is a leading malignancy in men, with current screening methods including digital rectal examination and prostate-specific antigen (PSA) tests.
  • There is a need for less invasive and potentially more accurate diagnostic tools for prostate cancer screening.

Purpose of the Study:

  • To review published reports on the use of urinary markers for prostate cancer diagnosis.
  • To assess the potential of urinary biomarkers as screening tools for prostate cancer.

Main Methods:

  • A PubMed-based literature search was conducted for studies published between 1985 and February 2006.
  • Search terms included 'urine', 'marker', and 'prostate cancer'.

Main Results:

Related Experiment Videos

  • Existing studies often utilized small cohorts and relied on prostate biopsies for histological confirmation.
  • The sensitivity and specificity of identified urinary markers varied widely, with limited data for each marker.
  • Urinary biomarker research for prostate cancer is a novel field with potential for non-invasive screening.

Conclusions:

  • Urinary biomarkers represent a promising, non-invasive approach for prostate cancer diagnosis and screening.
  • Further research is essential to identify and validate specific urinary 'signature markers' for malignancy.
  • Proteomic platforms offer potential for discovering next-generation urinary biomarkers.